Pricing & Access· August 18, 2026 · 16 min read
DTX401's August 23 PDUFA: Payers Face a Cornstarch-Replacement Gene Therapy
By Ran Chen#Gene Therapy#Rare Disease#Medicaid
Topic
Coverage Access
Formulary tiers, utilization management, patient support, and the access layer GoodRx and drug labels do not explain.
Pricing & Access· August 17, 2026 · 25 min read
Medicaid's September 10 Deadline: The Coverage Trade for GENEROUS Pricing
By Ran Chen#Medicaid#Drug Pricing#Payer Policy
Pricing & Access· August 17, 2026 · 25 min read
Tavneos on Formularies as FDA Moves to Withdraw: The Coverage Dilemma
Pricing & Access· August 16, 2026 · 18 min read
Hepatitis C Treatment Access in 2026: Generic Economics, PA, and Sobriety
Specialty· August 16, 2026 · 17 min read
Leqembi IQLIK Launches: Subcutaneous Lecanemab Moves to Specialty Pharmacy
Policy· August 16, 2026 · 15 min read
Ten PBMs Commit to TrumpRx Cash Prices in Real-Time Tools: The Policy Ledger
By Ran Chen#PBM#Payer Policy#Formulary Strategy
Specialty· August 15, 2026 · 25 min read
Kidney Transplant Immunosuppression: Part B-ID Cliff, Tacrolimus, & Access
By Ran Chen#Nephrology#Medicare Part B#Coverage Access
Pricing & Access· August 13, 2026 · 22 min read
IBD Treatment Access (2026): Stelara & Humira Biosimilars Meet IL-23
Specialty· August 4, 2026 · 13 min read
Narcolepsy & Idiopathic Hypersomnia Access: Wakefulness to Oxybates
By Ran Chen#Specialty Pharmacy#REMS#Prior Authorization
Pricing & Access· June 10, 2026 · 10 min read